v3.26.1
Stock-Based Compensation
6 Months Ended
Jun. 30, 2026
Retirement Benefits [Abstract]  
Stock-Based Compensation

Note 9 – Stock-Based Compensation

 

The Equity Incentive Plan provides for the Company to grant ISOs, and NSOs to employees, advisers, and directors. As of June 30, 2026 there were 15,111,193 equity awards authorized including 208,135 awards that were exercised to common stock.

 

Stock Options

 

Stock options represent the right to purchase shares of common stock on the date of exercise at a stated exercise price. The exercise price of a stock option generally must be at least equal to the fair market value of the common stock on the date of grant. Options vest over a period of time not to exceed 10 years from the grant date.

 

The terms of the plan permit certain option holders to exercise options before their options are vested, subject to certain limitations. Upon early exercise, the awards become subject to a restricted stock agreement. The shares of restricted stock granted upon early exercise of the options are subject to the same vesting provisions in the original stock option awards. Shares issued as a result of early exercise that have not been vested are subject to repurchase by the Company upon termination of the purchaser’s employment, at the price paid by the purchaser. Such shares are not deemed to be issued for accounting purposes until they vest.

 

The following table summarizes the Company’s stock option activity and related information:

 

  

Number of

Shares

  

Weighted

Average

Exercise Price

  

Aggregate

Intrinsic Value

(in thousands)

  

Weighted

Average

Remaining Life

 
Outstanding as of December 31, 2025   7,336,803   $0.76   $1,138,783    8.71 
Granted   8,039,908   $1.27   $-    - 
Exercised during period   -   $-    -    - 
Forfeited   10,631   $1.29   $-    - 
Expired   12,870   $1.15    -    - 
Outstanding as of June 30, 2026   15,353,210   $1.02   $1,186,016    9.01 

 

The aggregate intrinsic value of options is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s shares of common stock for those options that had exercise prices lower than the fair value of the Company’s shares of common stock.

 

 

As of June 30, 2026 and 2025, the total remaining unrecognized compensation expense related to non-vested stock options was $4,406 and $1,214, respectively, which will be amortized over the weighted-average period of 3.46 years and 3.80 years, respectively.

 

Total stock-based compensation expense for the three and six months ended June 30, 2026 and 2025 was as follows (in thousands):

 

   June 30, 2026   June 30, 2025   June 30, 2026   June 30, 2025 
   Three Months Ended   Six Months Ended 
   June 30, 2026   June 30, 2025   June 30, 2026   June 30, 2025 
Cost of sales  $4   $5   $19   $9 
Research and development   35    23    68    59 
Sales and marketing   11    -    18    16 
General and administrative   314    252    462    278 
Total stock-based compensation expense  $364   $280   $567   $362